Analysis of LV Lead Position in Cardiac Resynchronization Therapy Using Different Imaging Modalities  by Becker, Michael et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 3 , N O . 5 , 2 0 1 0
© 2 0 1 0 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 0 9 . 1 1 . 0 1 6Analysis of LV Lead Position in Cardiac
Resynchronization Therapy Using Different
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Michael Becker, MD,*† Ertunc Altiok, MD,* Christina Ocklenburg, MSC,‡
Renate Krings, MD,* Dan Adams, PHD,§ Michael Lysansky,§ Barbara Vogel, MD,*
Patrick Schauerte, MD,* Christian Knackstedt, MD,* Rainer Hoffmann, MD*
Aachen, Germany; and Haifa, Israel
O B J E C T I V E S This study sought to evaluate whether left ventricular (LV) lead position in cardiac
resynchronization therapy (CRT) can be determined by myocardial deformation imaging during LV
pacing and to compare imaging techniques for analysis of LV lead position.
B A C KG ROUND LV lead position has a signiﬁcant impact on effectiveness of CRT, but clinically
applicable methods to determine LV lead position are less deﬁned.
METHOD S In 56 patients (53  5 years, 34 men) undergoing CRT, ﬂuoroscopy and 2 myocardial
deformation imaging–based approaches were applied to determine the LV lead position. Myocardial
deformation imaging–based techniques were used to determine 1) the segment with maximal temporal
difference of peak circumferential strain before and while on biventricular CRT; and 2) the segment with
earliest peak systolic circumferential strain during pure LV pacing. Twelve-month echocardiography was
performed to determine LV remodeling and improvement in function. Optimal LV lead position was
deﬁned as concordance or immediate neighboring of the determined LV lead position to the segment
with latest systolic strain prior to CRT.
R E S U L T S LV lead position determined during LV pacing correlated to the position determined by
ﬂuoroscopy (kappa  0.761). Patients with optimal LV lead position had greater improvement in LV
ejection fraction and decrease in end-diastolic volume than those with nonoptimal LV lead position
(12  4% vs. 7  3%, p  0.001, and 28  13 ml vs. 14  8 ml, p  0.001, respectively). Determination
of the LV lead position based on myocardial deformation imaging during LV pacing showed greater
discriminatory power for improvement of ejection fraction (difference optimal vs. nonoptimal lead
position group: 4.64  1.01 ml; p  0.001) than deformation imaging with biventricular pacing (3.03 
1.08 ml; p  0.007) and ﬂuoroscopy (2.22  1.12 ml; p  0.053).
CONC L U S I O N S Myocardial deformation imaging during LV pacing allows determination of the LV
lead position in CRT. Improvement in LV function and remodeling as indicators of optimal LV lead
position can be best predicted by LV lead position analysis during LV pacing. (Left Ventricular Lead
Position in Cardiac Resynchronization Therapy; NCT00748735) (J Am Coll Cardiol Img 2010;3:472–81)
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473ardiac resynchronization therapy (CRT)
has been shown to improve symptoms and
left ventricular (LV) function, and induce
reverse remodeling (1,2). However, about
ne-third of patients do not respond to CRT (1–5).
V pacing lead position has recently attracted
ttention and is likely to have a considerable impact
n CRT success (6–11). The LV lead should be
laced in the area of greatest delay in electrical
ctivation and mechanical contraction to achieve
ptimal resynchronization effect (10). Thus, guid-
nce of LV lead to this site is desirable. It would
equire an imaging modality that can identify the
btained LV lead position in relation to the site of
aximal mechanical dyssynchrony (MMD). The
V lead position can be determined by fluoroscopy.
owever, the site of MMD prior to CRT is
ormally defined by echocardiography. We have
ecently described definition of LV lead position
ased on myocardial deformation imaging (MDI)
efore and while on biventricular CRT (8). Con-
ordance of the LV lead position and the LV
egment with latest contraction prior to CRT re-
ulted in significantly better effectiveness of CRT
9). However, this analysis is complex. Determina-
ion of the LV area with earliest contraction during
ere LV pacing may be an attractive alternative to
efine the LV lead position. This approach is based
n the assumption that the LV lead induces the
arliest electrical and mechanical activation.
The LV lead position was determined in this
tudy using: 1) fluoroscopy; 2) change in myocardial
eformation sequence from pre-implant to on
RT; and 3) the site of earliest contraction during
ure LV pacing. Improvement in LV ejection
raction (EF) and LV remodeling during a 12-
onth follow-up were evaluated. The imaging
odality to most accurately define the LV lead
osition was determined based on the discrimina-
ory power of the method for improvement in
VEF and LV remodeling during follow-up
etween an optimal and a nonoptimal LV lead
osition group. This end point was used because
f previous experimental and clinical findings
ndicating that optimal LV lead position relative
o the LV site with latest contraction prior to
RT results in highest CRT effectiveness (6 –
1). Thus, the highest discriminatory power of a
echnique for improvement in LVEF and remod-
ling is a function of accurate definition of the
V lead position relative to the LV site with
MD prior to CRT. tE T H O D S
atients. Fifty-six consecutive patients (mean age
3  5 years, 34 men) with end-stage heart failure
nd sinus rhythm, scheduled for implantation of a
iventricular pacemaker, were included in the study.
riteria for implantation were New York Heart
ssociation (NYHA) functional class III (n  35)
r IV (n  21) despite optimal pharmacologic
herapy, LV systolic dysfunction with EF 35%,
nd a QRS width 120 ms due to left bundle
ranch block. Forty patients had a myocardial
nfarction within the last year. In 16 patients, the
tiology of heart failure was nonischemic. This
tudy was approved by the local ethical committee,
nd all subjects gave written informed consent.
iventricular device implantation. All patients re-
eived a biventricular cardioverter-defibrillator
Attain-System with InSync Marquis,
edtronic, Minneapolis, Minnesota, n 
6; or Aesula-System with Epic HF
-339, St. Jude Medical, St. Paul, Min-
esota, n  20).
The LV lead was inserted by a trans-
enous approach through the coronary
inus into a cardiac vein of the free wall.
he aim was to achieve an optimal LV
ead position intraoperatively by minimiz-
ng the width of the QRS complex and
ptimizing hemodynamic parameters (in-
rease arterial systolic pressure). An aver-
ge of 2.1  0.5 veins were evaluated for
his purpose. The right atrial and ventric-
lar leads were positioned conventionally.
The ventrioventricular (VV) timing was
et to 0. To determine the optimal atrioven-
ricular (AV) time, Doppler echocardiography was
sed post-operatively as described before (8). Optimal
V time was between 100 and 150 ms (mean time
24  11 ms) in 54 patients and between 70 and 85
s (mean time 77  7 ms) in 2 patients. One day
fter CRT implantation, the device was repro-
rammed to pure LV pacing for a short period to
llow echocardiographic examination with this pacing
etting. At 6- and 12-month follow-up, the device
as controlled to ensure that no LV lead dislocation
ad occurred and that the AV timing was stable.
luoroscopy. After CRT implantation, biplane flu-
roscopy in orthogonal views (left anterior oblique
LAO] 60° and right anterior oblique [RAO] 30°)
as performed. These images were analyzed by 2
linded readers to determine the anatomical loca-
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474The intraobserver variability was found to be
appa  0.92 (95% confidence interval [CI]: 0.85
o 0.95), and interobserver variability was found to
e kappa  0.89 (95% CI: 0.82 to 0.97).
chocardiography. All studies were performed be-
ore CRT, 1 day after CRT implantation, and at
2  2 months follow-up using a Vivid Seven
igital ultrasound scanner (General Electric,
orten, Norway). Using apical 4- and 2-chamber
iews, left ventricular end-diastolic volume
LVEDV), left ventricular end-systolic volume
LVESV), and EF were determined employing
iplane Simpson’s method. Patients with a reduc-
ion of 15% in LVEDV were considered to be
dequate clinical responders. Definition of clinical
esponse was not based on optimal LV lead posi-
ioning. Four parasternal short-axis views (mitral
alve level, papillary muscle level, apical level, and
n additional apex view) were acquired using
-dimensional tissue harmonic imaging. For opti-
ized characterization of myocardial tissue, the
ocus was adjusted to the center of the LV cavity,
nd the frame rate was between 56 and 92 frames/s.
nalysis of myocardial deformation. Myocardial de-
ormation analysis was performed offline on a per-
onal computer with the aid of a customized soft-
are package (EchoPAC BT 05.2, General
lectric) using 2 consecutive cardiac cycles as de-
cribed before (9,13,14). Echocardiographic image
uality was adequate for strain analysis in 89% of all
egments. Time curves of circumferential strain
CS) were used to define the segment with latest
Figure 1. Determination of the LV Lead Position Using Fluorosc
Orthogonal ﬂuoroscopy views (right anterior oblique [RAO] 30° and lef
therapy (CRT) implantation to determine the anatomical left ventricula
lead position in the basoapical direction (I: basal level, II: mid-ventricula
deﬁned as 1 cm apical to the LV lead course within the great cardiac v
position within the circumference of that level. For this purpose, the 1
the tip of the LV lead (arrows) to be in the lateral medial segment. Adeak negative CS before CRT in relation to the sRS complex within a 17-segment model. This
egment was assumed to have the greatest need for
esynchronization and to be the optimal LV lead
osition.
Furthermore, based on strain curve analysis, 2
ethods to determine the LV lead position were
pplied: 1) definition of the segment with maximal
emporal difference in peak CS pre-implant before
nd while on biventricular CRT (Fig. 2); and 2)
efinition of the segment with earliest peak systolic
S during pure LV pacing 1 day after implantation
f the CRT system (Fig. 3).
Variability data were calculated as relative devia-
ions between 2 measurements. For time-to-peak
egative CS, intraobserver variability was found to
e 5.3 1.9% of the absolute measured time values,
nd interobserver variability was 8.2  2.2%.
eﬁnition of optimal LV lead position. Considering
he LV lead position defined either by fluoroscopy
r the 2 deformation imaging–based methods, the
istance between the segment with MMD and the
efined LV lead position was counted in number of
egments referring to the 4 apicobasal levels and the
p to 6 segments within 1 circumference. One
istance step was related either to the apicobasal
evel or to the circumferential level. Optimal posi-
ion of the LV lead was defined as concurrence or
mmediate neighboring (1 distance step) of the
egment with MMD and the segment with as-
umed location of the LV lead. Definition of
ptimal LV lead position was not based on clinical
(Method 1)
terior oblique [LAO] 60°) acquired after cardiac resynchronization
) lead position. The RAO view (left panel) was used to deﬁne the LV
vel, III: apical level, IV: apex). The basal border of the basal level was
The LAO view (right panel) was subsequently used to deﬁne the
ment scheme was projected onto the LAO view. The images show
d, with permission, from Cerqueira et al. (12).opy
t an
r (LV
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7-seguccess of CRT during follow-up.
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475eak oxygen consumption. Patients underwent bicy-
le cardiopulmonary exercise testing (10 W per min
ncrements) at baseline and after 12 (2) months of
RT. Maximum oxygen consumption (VO2max) at
eak exercise was defined as the highest oxygen
onsumption measured during the symptom-
imited exercise test and expressed as milliliters per
ilogram per minute.
tatistics. Continuous data are expressed as mean
alues SD and compared using the Student t test.
e considered LVEDV and EF as relevant param-
ters to compare the ability of the imaging tech-
iques to differentiate between optimal and nonop-
imal lead position groups. Differences of the group
eans and the corresponding confidence limit were
alculated, concluding that the farther away the
ean difference is from 0 difference, the better the
echnique is able to discriminate between optimal
nd nonoptimal groups. Categorical data were pre-
ented as frequencies and compared with the Fisher
xact test. Spearman rank correlation coefficient was
sed to show correlation between change in
VEDV and EF with distance between the seg-
ent with MMD and LV lead position. To eval-
ate agreement between anatomical LV lead posi-
ion determined by fluoroscopy and assumed LV
Local: Circumferential Strain (%)
t pre
-32.0
0 300 600 900
-21.3
-10.7
0.0
10.7
21.3
32.0
Figure 2. Determination of the LV Lead Position From Deforma
Left panel: Myocardial deformation imaging prior to cardiac resync
ings for the 6 evaluated segments within the circumference. The do
ments. The time difference between the segment with the earliest
Right panel: Myocardial deformation imaging demonstrating circum
circumference while on biventricular pacing. The time difference be
(∆t post) is marked with a red arrow. The tracing obtained prior to
from before to during CRT) is added as the dashed green line. The
apy for this segment (∆t pre-post) is marked by the yellow arrow. I
patient indicating the LV lead position deﬁned by this approach.ead position determined by either method of CS 4nalysis, we calculated Cohens kappa coefficient
nd weighted Cohens kappa coefficient with 95%
I as appropriate. To define intraobserver and
nterobserver variability in 10 subjects, analyses
ere repeated by the same observer and performed
n addition by a second independent observer. A
value of 0.05 was considered statistically
ignificant.
E S U L T S
aseline clinical characteristics prior to CRT are
iven in Table 1. Thirty-six of the 56 patients
64%) were classified as clinical responders (reduc-
ion of LVEDV 15%). Considering the LV lead
osition defined during LV pacing to determine
atients with optimal and nonoptimal LV lead
osition, 31 of the 36 clinical responders had
ptimal LV lead position. In the clinical nonre-
ponders, there were 5 patients with optimal and 15
atients without optimal LV position.
ocation of MMD prior to CRT. The location of the
egment with latest maximal systolic strain prior to
RT was as follows: 14 anterior (8 basal, 6 medial),
6 lateral (15 basal, 8 medial, 3 apical), 9 posterior
3 basal, 6 medial), 3 inferior (1 basal, 2 apical), and
Local: Circumferential Strain (%)
t post
t pre-post
0
•
300 600 900
Imaging Before and With Biventricular Pacing (Method 2)
ization therapy (CRT) demonstrating 6 circumferential strain trac-
black line indicates the mean circumferential strain of all 6 seg-
the latest peak strain (∆t pre) is marked with an orange arrow.
ntial strain tracings from the 6 evaluated segments within the
en the segment with earliest and latest peak strain during CRT
from the lateral segment (greatest change in time to peak strain
uction in contraction delay with CRT compared with prior to ther-
s greatest among all 17 left ventricular (LV) segments of thistion
hron
tted
and
fere
twe
CRT
red
t waat the apex. The distribution of the segment with
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476atest contraction prior to CRT was not different
etween patients found to have optimal and those
ound to have nonoptimal LV lead position, inde-
endent of the imaging modality used.
al: Circumferential Strain (%)=-17.19        T=929 msec
0.0
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0.0
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3. Determination of the LV Lead Position From Deformation
g During Pure LV Pacing (Method 3)
ferential strain tracings from the 6 evaluated segments within the
ference during pure left ventricular (LV) pacing. The segment with
t peak circumferential strain among all 17 LV segments of this
t was deﬁned as LV lead position by this approach (black arrow).
acteristics at Baseline Before CRT
Optimal LV Lead
Position
(n  36)
Nonoptimal LV Lead
Position
(n  20) p Value
52 7 55 9 0.882
24 (66%) 12 (60%) 0.572
thy 26 (71%) 15 (74%) 0.232
ms 161 21 160 23 0.689
3.2 0.6 3.1 0.8 0.552
301 86 306 82 0.332
211 62 219 57 0.413
31 5 30 7 0.481
28 (77%) 15 (73%) 0.127
6 (18%) 4 (21%) 0.294
33 (91%) 18 (90%) 0.655
15 (43%) 8 (38%) 1.000
17 (47%) 9 (44%) 0.772
ists 25 (70%) 14 (68%) 0.165
versus nonoptimal left ventricular (LV) lead position is based on myocardial
g pure LV pacing.
rting enzyme; ARB  angiotensin II receptor blocker; CRT  cardiac resynchro-
left ventricular end-diastolic volume; LVEF left ventricular ejection fraction;fd-systolic volume; NYHA  New York Heart Association.ocation of the LV lead position. Figure 4 demon-
trates the LV lead position based on findings by
uoroscopy and both strain analysis methods. LV
ead position was found to be different in 6 patients
y strain analysis before and while on CRT, and in
patients by fluoroscopy (Fig. 4).
Kappa analysis demonstrated good agreement
etween the 3 different methods used to define LV
ead position with regard to 1) segmental analysis;
) distance between the segment with determined
V lead position and the segment with MMD prior
o CRT; and 3) classification of the LV lead
osition as optimal or nonoptimal (Table 2). The
istance between the LV lead position defined by
uoroscopy and the LV lead position defined by strain
nalysis during biventricular pacing or during pure LV
acing was 0.1  0.7 (range: 0 to 2) segments and
.2  0.7 (range: 0 to 2) segments, respectively.
ptimal versus nonoptimal LV lead position. Consid-
ring the location of MMD prior to CRT, the
osition of the LV lead was in agreement or in the
mmediate neighborhood (optimal LV lead position)
n 33 patients using fluoroscopy, in 33 patients using
train analysis during biventricular pacing, and in 36
atients using strain analysis during pure LV pacing.
mpact of CRT on LV dyssynchrony. Considering def-
nition of optimal LV lead position in patients
ased on LV pacing analysis, the maximal temporal
ifference between the segment with earliest and
atest peak negative CS before CRT was 161  21
s in the optimal LV lead position group and
60  23 ms in the nonoptimal LV lead position
roup (p 0.689). With active CRT, this temporal
ifference was significantly reduced in both groups
optimal: 113  16 ms, and nonoptimal: 122  19
s, p  0.001). The reduction was 21% higher in
he optimal LV lead position group (48 11 ms vs.
8  16 ms, p  0.027).
mpact of CRT on LV function, remodeling, and exercise
apacity related to LV lead position. Comparison of
aseline and 12-month follow-up results demon-
trated a greater increase in LVEF, reverse remod-
ling, and VO2max for patients with optimal LV
ead position compared with the nonoptimal LV
ead position group. This benefit was present inde-
endent of the modality chosen for definition of the
V lead position (Table 3). Additionally, there was
significantly greater improvement in NYHA
unctional classification (optimal: 1.6  0.4 classes
nd nonoptimal: 0.9  0.6 classes, p  0.031).
The improvement in LVEF at 12-month
ollow-up and the reduction in LVEDV atLoc
-2
-1
-
1
2
Figure
Imagin
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earliesTable 1. Patient Char
Age, yrs
Males/females
Ischemic cardiomyopa
QRS interval duration,
NYHA functional
classiﬁcation
LVEDV, ml
LVESV, ml
LVEF, %
Concomitant therapy
ACE inhibitors
ARBs
Beta-blockers
Digitalis
Diuretics
Aldosterone antagon
Determination of optimal
deformation imaging durin
ACE  angiotensin-conve
nization therapy; LVEDVollow-up correlated to the distance between the
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477egment with MMD and the segment with LV lead
osition based on pure LV pacing (r  0.53, p 
.001 and r  0.50, p  0.001, respectively) (Fig. 5).
omparison of imaging modalities to determine LV
ead position. Imaging modalities were compared
ith regards to their ability to accurately determine
V lead position. This analysis was based on the
iscriminatory power of each method for improve-
ent in LVEF, LV remodeling, and VO2max
uring follow-up between an optimal and a nonop-
imal LV lead position group. Determination of the
V lead position during LV pacing showed greatest
ifferences, indicating greatest accuracy in the anal-
sis of LV lead position (Table 3).
I S C U S S I O N
he major findings of this study are: 1) in 40% of
atients undergoing CRT, the position of the LV
ead did not match the site of MMD; 2) myocardial
eformation analysis during pure LV pacing al-
owed definition of LV lead position; 3) a match of
he identified LV lead position and the area dem-
nstrating MMD prior to CRT resulted in signif-
cantly greater increase in LV function and negative
V remodeling; and 4) definition of the LV lead
osition based on myocardial deformation analysis
uring pure LV pacing allows better distinction
etween optimal and nonoptimal LV lead position,
s indicated by the improvement in LV function
nd reverse remodeling at follow-up, than defini-
ion by fluoroscopy.
ptimal LV lead position in CRT. Approximately 30%
o 50% of patients remain unresponsive to CRT
espite adherence to current guidelines. Optimal
V pacing site has increasingly been focused on as
n important technical determinant of CRT suc-
ess. Experimental data have demonstrated that the
V lead position should be in the area of the latest
ontraction prior to CRT (6,10). An animal study
sing cardiac magnetic resonance proved that re-
Table 2. Concordance Between the 3 Different Modalities Used
LV Lead Position (Segment)
Weighted Kappa Value
Value 95% CI
A and B 0.830 0.705 0.952
A and C 0.855 0.731 0.972
B and C 0.761 0.679 0.843
Concordance of the 3 methods is with regard to 1) segment with the left vent
with maximal dyssynchrony prior to cardiac resynchronization therapy; and 3)
myocardial deformation imaging during biventricular pacing; B  myocardial d
CI  conﬁdence interval.ions with maximal resynchronization after CRT
lso exhibited maximum gain in systolic LV func-
ion (15). This should be the optimal region for the
V lead. One study showed that those patients
42%) who were paced at the site of latest activation
chieved significant improvements in LVEF,
VESV, and exercise tolerance, whereas patients
aced at different sites (58%) failed to show an
mprovement (6). In a study on 64 patients,
uffoletto et al. (16) demonstrated that patients
ith concordance between LV lead position and
ite of MMD had a larger increase in LVEF at
ollow-up. These findings were confirmed in a
tudy by Murphy et al. (7) using 3-dimensional
issue synchronization imaging. Recently, a study
n 244 patients demonstrated that a LV lead
osition concordant to the site of latest activation
rior to CRT resulted in significantly more re-
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Figure 4. Allocation of LV Lead as Deﬁned by Different Imaging
Modalities
Position of the left ventricular (LV) lead for all 56 patients in the 17
LV model as deﬁned by ﬂuoroscopy (anatomical lead position, show
red), as deﬁned by circumferential strain analysis before and with c
resynchronization therapy (shown in blue), and as deﬁned by circum
tial strain analysis during LV pacing (shown in black).
eﬁne LV Lead Position
Distance (Number of Segments)
Classiﬁcation of
Nono
Weighted Kappa Value K
Value 95% CI Value
0.806 0.689 0.924 0.762 0
0.720 0.636 0.805 0.710 0
0.752 0.511 0.935 0.784 0
r (LV) lead position; 2) distance between the segment with determined LV lead p
lassiﬁcation of the LV lead position as optimal or nonoptimal. The methods are
mation imaging during LV pacing; and C  ﬂuoroscopy.teral
-segment
n in
ardiac
feren-to D
Position (Optimal/
ptimal)
appa
95% CI
.556 0.897
.681 0.840
.604 0.879
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478erse remodeling and lower hospitalization-free
ortality rates during long-term follow-up (11).
To overcome potential difficulties in the optimal
lacement of the LV lead, epicardial lead placement
as been suggested (17–19). More recently, even
he placement of 2 LV leads has been proposed to
mprove the effectiveness of CRT (20,21).
Thus, a technique that will help to implant the
V lead into the area of greatest mechanical and
lectrical need is likely to improve the success rate
f CRT. This would require accurate definition of
he LV lead position relative to the site of MMD.
urrent difficulties relate to the problem of match-
ng the LV lead site obtained in the catheterization
Table 3. LVEF, LVEDV, and VO2max Before CRT and at 12-Month
LVEF, %
Optimal LV lead position group
Baseline LVEF, %
Follow-up LVEF, %
∆LVEF, (%)
Nonoptimal LV lead position group
Baseline LVEF, %
Follow-up LVEF, %
∆LVEF, (%)
Difference in ∆LVEF, % (optimal – nonoptimal group) (95% CI)
p Value ∆LVEF (optimal vs. nonoptimal LV lead group) LVEDV, m
LVEDV, ml
Optimal LV lead position group
Baseline LVEDV, ml
Follow-up LVEDV, ml
∆LVEDV, ml
Nonoptimal LV lead position group
Baseline LVEDV, ml
Follow-up LVEDV, ml
∆LVEDV, ml
Difference in ∆LVEDV, ml (optimal – nonoptimal group) (95% CI)
p Value ∆LVEDV (optimal vs. nonoptimal LV lead group)
VO2max, ml/kg/min
Optimal LV lead position group
Baseline VO2max, ml/kg/min
Follow-up VO2max, ml/kg/min
∆VO2max, ml/kg/min
Nonoptimal LV lead position group
Baseline VO2max, ml/kg/min
Follow-up VO2max, ml/kg/min
∆VO2max, ml/kg/min
Difference in ∆VO2max, ml/kg/min (optimal – nonoptimal group)
p Value for ∆VO2max (optimal vs. nonoptimal LV lead group)
Shown are the optimal and nonoptimal left ventricular (LV) lead position group
parameter, the difference between optimal and nonoptimal LV lead position gr
LV lead position.
CRT  cardiac resynchronization therapy; VO2max  maximum oxygen consuab with the area of MMD defined before by pchocardiography or cardiac magnetic resonance.
luoroscopy has limitations in defining the LV lead
osition in 3-dimensional space and lacks informa-
ion on the area of MMD. We have recently
escribed a technique to identify the LV lead
osition based on a detailed analysis of myocardial
eformation before and while on CRT (8,9). The
echnique resulted in high agreement with the LV
ead position defined by fluoroscopy and by com-
uted tomography. It has the advantage of allowing
efinition of the area of MMD and the LV lead
osition within 1 imaging modality. However, the
omplex analysis limits its applicability. Thus, it has
een impractical for optimization of the LV lead
llow-Up
Biventricular Pacing LV Pacing Fluoroscopy
32 5 31 5 31 5
43 5 43 6 42 6
11 3 12 4 11 3
29 7 30 7 30 7
37 5 37 6 38 6
8 4 7 3 8 4
3.0 (0.9–5.2) 4.6 (2.6–6.7) 2.2 (0.0–4.5)
0.0072 0.0001 0.0528
304 88 301 86 302 88
279 83 273 82 277 84
25 13 28 13 25 14
303 81 306 82 306 80
285 82 292 82 289 81
18 11 14 8 17 11
6.6 (0.2–13.4) 13.9 (7.7–20.0) 7.6 (0.9–14.3)
0.0551 0.0001 0.0273
13.4 1.8 13.6 1.9 13.9 1.8
15.4 2.0 16.2 1.9 16.5 1.8
2.1 0.9 2.6 0.9 2.5 0.9
14.0 1.9 13.8 1.8 13.2 1.9
15.7 1.9 15.4 2.0 15.0 1.9
1.7 1.0 1.7 0.9 1.8 1.2
CI) 0.4 (0.1–0.7) 0.9 (0.2–1.3) 0.7 (0.1–1.5)
0.0544 0.0117 0.0303
eﬁned by the different modalities to determine the LV lead position. For each
is greatest if deformation imaging during LV pacing is used to determine the
on; other abbreviations as in Tables 1 and 2.Fo
l
(95%
s as d
oupsosition during the implantation procedure. In this
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479tudy, we evaluated another approach based on
DI. The segment with earliest mechanical activ-
ty during pure LV pacing was assumed to represent
he area of earliest electrical activation and thus the
V lead position. This technique, while still indi-
ectly defining the LV lead position, is considerably
asier.
This study demonstrated that the spatial rela-
ionship between LV lead position defined by any
f the 3 applied imaging modalities and the area of
MD prior to CRT is predictive for improvement
n LV function and reverse remodeling with CRT.
his finding supports the importance of the LV
ead position for the CRT success. Furthermore,
he spatial relationship of the LV lead position
efined during LV pacing and the area of MMD
rior to CRT had the best predictive power for
mprovement in LV function and reverse remodel-
ng with CRT. This may be explained in part by the
east complex analysis technique not requiring the
atching of multiple imaging modalities or defor-
ation imaging sets obtained at different time
oints. In this study, CS analysis was used because
t has been proven to allow accurate analysis of LV
yssynchrony and assessment of the potential CRT
enefit. Radial strain might also be used to evaluate
yssynchrony. However, this study was not in-
ended to compare radial and CS for analysis of
yssynchrony. Future studies should compare ra-
Number of Segments Between Maximal
Dyssynchrony and LV Lead Position
(%
)
LVEF Baseline – Follow-up
15
10
5
0
0 1 2 3 4
Figure 5. Changes in LVEF and LVEDV Related to Displacement
(Left panel) change in left ventricular ejection fraction (LVEF) from
ment with maximal dyssynchrony prior to cardiac resynchronization
pure LV pacing. (Right panel) change in LV end-diastolic volume (L
between the segment with maximal dyssynchrony prior to CRT to tial, circumferential, and longitudinal strain param- aters for prediction of improvement in EF and
eduction in LV dimensions.
Analysis of LV lead position during LV pacing
as the potential to be used during CRT implan-
ation for definition and optimization of the LV
ead position, thereby improving the CRT success
ate. Further studies will have to be performed to
alidate this concept.
tudy limitations. The segment with earliest con-
raction during LV pacing was considered the LV
ead position. This is based on the hypothesis that
he mechanical activation sequence will follow the
lectrical activation pathway. This hypothesis has
ot been proven in experimental studies. However,
he considerable concordance of the LV lead posi-
ion defined by this concept and the fluoroscopic
esults support this approach.
Great improvement in LV function was used as
ndicator of optimal LV lead position. The com-
arison of imaging modalities regarding their ability
o define the accurate LV lead position was done
ndirectly by considering their discriminating power
or improvement in LV function and remodeling.
his was done on the basis that only a modality that
llows accurate definition of the LV lead position
llows best analysis of the spatial relationship be-
ween LV lead position and the area of MMD prior
o CRT. Spatial concordance is considered a re-
uirement for greater CRT success. However, there
LVEDV Baseline – Follow-up
Number of Segments Between Maximal
Dyssynchrony and LV Lead Position
(m
l)
0
20
40
60
0 1 2 3 4
V Lead
line to 12-month follow-up related to distance between the seg-
rapy (CRT) to the segment with LV lead position deﬁned during
V) from baseline to 12-month follow-up related to distance
egment with LV lead position deﬁned during pure LV pacing.-
-
-
of L
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VEDre other parameters that might have an impact on
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480RT success. Lack of viability or scarring was not
valuated in this study as a potential mechanism for
educed CRT effect (22,23). However, the lack of
iability analysis is unlikely to have an impact on the
urrent results, because the distribution of ischemic
ardiomyopathy was equal between the optimal and
he nonoptimal LV lead position groups. The
efinition of the optimal LV lead position as
oncurrence or immediate neighborhood of the
egment with maximal temporal difference in peak
egative CS before and with CRT to the segment
ith MMD prior to CRT is arbitrary. A different
efinition of optimal lead position would have
esulted in a higher number of patients with
ptimal lead position. However, there was a
ontinuous reduction of LV reverse remodeling
n CRT with increasing distance between LV
ead position and the segment with latest con-
raction prior to CRT.
There are technical factors that may limit the use
f the described analysis method for optimal LV
ead placement: some patients may have scar for-
ation not allowing sufficient electrical response inHeart Failure (PATH-CHF) Study
Group. Long-term clinical effect of apy stimulation sitaximal delayed segment in a region where a LV
ead cannot be placed due to absence of a suitable
ein or the impossibility of reaching that vein.
O N C L U S I O N S
nalysis of the myocardial deformation sequence
uring pure LV pacing allows determination of
RT LV lead position. Concurrence of the LV lead
osition and the LV segment with MMD prior to
RT results in optimized effectiveness of CRT on
V function and reverse remodeling at 12-month
ollow-up. Definition of the LV lead position based
n myocardial deformation analysis during pure LV
acing allows better distinction between optimal
nd nonoptimal LV lead position as indicated by
he improvement in LV function and reverse re-
odeling at 12-month follow-up than definition of
he LV lead position by fluoroscopy.
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ann, Medical Clinic I, University RWTH Aachen,
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